Detalhe da pesquisa
1.
Appraising research policy instrument mixes: a multicriteria mapping study in six European countries of diagnostic innovation to manage antimicrobial resistance.
Res Policy
; 50(4): 104140, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941992
2.
A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA.
Sociol Health Illn
; 34(2): 234-50, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22118240
3.
Supporting the vital role of boundary-spanning physician researchers in the advancement of medical innovation.
Future Healthc J
; 8(2): e210-e217, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34286187
4.
The phantom menace of gene patents.
Nature
; 458(7237): 407-8, 2009 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19325609
5.
DNA patenting: the end of an era?
Nat Biotechnol
; 25(2): 185-7, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17287750
6.
A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance.
Appl Health Econ Health Policy
; 18(1): 69-79, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31541361
7.
Putting pharmacogenetics into practice.
Nat Biotechnol
; 24(4): 403-10, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16601719
8.
Continental drift? Do European clinical genetic testing laboratories have a patent problem?
Eur J Hum Genet
; 27(7): 997-1007, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846855
9.
Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.
Pharmacogenomics
; 7(5): 783-92, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16886902
10.
Authors' Reply to Hays: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance".
Appl Health Econ Health Policy
; 18(3): 459-460, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201931
11.
Reply to C.D. Richter.
Eur J Hum Genet
; 28(5): 537-538, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066933
12.
Is primary care the right place for genetic diagnosis?
Br J Gen Pract
; 57(542): 750-1, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17761066
13.
Shares in the human genome--the future of patenting DNA.
Nat Biotechnol
; 20(12): 1185-8, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12454661
14.
Biomarker patents for diagnostics: problem or solution?
Nat Biotechnol
; 30(6): 498-500, 2012 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22678384
15.
Innovation policy instruments (non-price) for medical innovation
Oslo Medicines Initiative technical report;
Monografia
em Inglês
| WHOLIS | ID: who-361755
16.
Инструменты политики (не связанные с ценовыми факторами) в поддержку инноваций в области медицины: Технический доклад Инициативы Осло по лекарственным средствам: основные положения.
Копенгаген; Всемирная организация здравоохранения. Европейское региональное бюро; 2022-09. (WHO/EURO:2022-6094-45859-66036).
em Russo
| WHOLIS | ID: who-362505
17.
Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?
Expert Rev Neurother
; 6(12): 1765-7, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17181421
18.
Innovation policy instruments (non-price) for medical innovation. Web-Annex: innovation policy instruments for new medicines
Copenhagen; World Health Organization. Regional Office for Europe; 2022.
em Inglês
| WHOLIS | ID: who-362113